PHA
CN
Our Mission
Vision and Values
管理团队
由学术界、商业界和产业界人士共同组成
陈国强 教授
清华大学合成与系统生物学中心主任
全球顶尖合成生物学专家，代谢工程领域的领军型人物，清华大学教授、合成与系统生物学中心主任，国家973“合成生物学”项目以及国家重大专项项目的首席科学家，也是中国首位“国际代谢工程奖(IMES Award)”获得者。
陈国强教授同时是全球合成生物学顶级期刊 Synthetic and Systems Biotechnology(《合成和系统生物技术》,简称SSB)担任共同主编，并在国际学术期刊如Chemical Reviews 、Chemical Society Reviews等上共发表微生物技术和生物材料相关论文400多篇，Web of Science引用两万五千多次，H指数78获得授权专利50多项，50个公开专利。
徐绚明
PhaBuilder 董事长
徐绚明女士作为 PhaBuilder 的董事长，始终致力于引入创新管理机制，加速全球化业务布局，将 PhaBuilder 打造成为用合成生物学服务全球的领头羊企业。
徐绚明女士长期致力于低碳可持续发展事业，接近20年的跨国公司高层管理经验，⻓期任职于世界500强企业⻄⻔子，以国际化视野赋能企业数字化转型，实现ESG目标，推动中国低碳相关行业的标准体系构建以及标志性项目落地实施。曾引领创新型解决方案业务从0到1的探索，同时在跨国企业战略定位、产品开发、市场营销、产业链融合、模式创新方面都有深厚的积淀。
笃信 PhaBuilder 能够以“微小改变世界，构建绿色未来”的理念造福人类，以“下一代工业生物技术”为引擎，为百行千业创造出高性能材料，应用于千变万化的场景，让PHA Life成为深入人心的新型生活理念，持续推动人类走向绿色未来。 徐绚明女士本科毕业于清华大学热能工程系，硕士毕业于清华大学经管学院与MIT斯隆管理学院的国际工商管理，后续在美国UCLA安德森商学院及美国斯坦福商学院进行创业和创新的探索。
  • 吴赴清
    联合创始人
    合成生物学及科研成果转化专家，博士，北京市政协委员，中国生物工程学会生物基材料专业委员会委员，清华大学生命学院副研究员。吴赴清先生在合成生物学科研领域及产业化成果转化方面有丰富经验，曾主持国家自然科学基金3项，发表论文40余篇，申请专利15项。
  • 兰宇轩
    副总裁
    全球知名合成生物学领域创业领袖，对全球合成生物学市场趋势以及产业化发展有着深刻的理解。
    2021年，他作为创始团队成员，共同参与创立了创新合成生物学企业 PhaBuilder ，利用全新嗜盐菌底盘推动包括PHA、四氢嘧啶等合成生物学产品的市场化。
  • 欧阳鹏飞
    副总裁
    清华大学生物学博士，工商管理博士后。在合成生物学及生物化工领域拥有近10年一线研究经验，发表并申请多项SCI论文及发明专利，在校期间曾担任清华大学生命学院研究生会主席。2018年后从事产业咨询研究工作，并进入清华经管学院联合培养博士后研究，担任助理研究员，对全球生命健康新技术新产业的研判和投资分析有深入的理解，2020年在Venture lab of DeepTech从事合成生物学的孵化和投资，2023年加入北京 PhaBuilder 担任副总裁。
  • 王竞辉
    技术研发VP
    近11年技术研发工作经验，曾任欧莱雅高级经理，拥有多年研发上中下游管理经验，协调推进全球创新项目，搭建合成生物平台，化学及生物工程学博士。
  • 丛立双
    生产副总经理
    12年从事发酵类原料药、医药中间体行业研发、生产、产业化放大及GMP生产全过程工作经验；万吨工厂管理经验擅长生产管理，微生物学硕士、高级工程师。
Your Current Location: Home · About Us · Development History ·
About Us
PhaBuilder: Focused on the Biomanufacturing of PHA.
Committed to bringing a better green life to people

PhaBuilder's technology is derived from Tsinghua University, initiated and founded by Professor George Guo-Qiang CHEN, a top global synthetic biology expert and the first Chinese recipient of the IMES Award (International Metabolic Engineering Award).

Relying on a self-developed halophilic bacterial chassis system for 30 consecutive years, PhaBuilder continuously develops its core product PHA (Polyhydroxyalkanoate) and promotes the realization of the PHA-based "4P" strategy for enterprise. This includes PHAmily (continuously exploring the PHA family with over 10 billion combinations), PHAbrary (a series of polymer material application solutions), PHAdustry (Industry 4.0 in the era of biomanufacturing, and global industrialization based on the NGIB(Next Generation Industrial Biotechnology) system commercialization of PHA).

PhaBuilder also possesses unique non-grain biomanufacturing technology and is currently constructing the world's largest "NGIB" production line with an annual capacity of 30,000 tons. In the future, PhaBuilder will provide sustainable solutions based on green bio-based materials to global customers by positioning itself as “a global leader in synthetic biology and bio-manufacturing”.

  • Industry
    Partners
PhaBuilder Strategy
PhaBuilder '4P' Strategy
PHAmily
PHAmily
Exploring PHAs
Over 10 billion Combinations
The Diverse Family of PHAs
PHAbrary
PHAbrary
Applications Development
Performance Meet Customer Requirements
Material Application Database
PHAdustry
PHAdustry
Industrialization
PHA Complete Solution
Entering into a Myriad of Industries
PHA Life
PHA Life
Commercialization
Reaching the End Customers
Reaching into Thousands of Households
Development History
PhaBuilder Development History
1994
The founder returned to China and joined Tsinghua University.
Commencing 30 years of research in synthetic biology.
2021
PhaBuilder Company Established
Takes the lead in completing 200-ton scale production
2022
Establishment of a Flexible Manufacturing Line (Beijing)
Create a Benchmark for Biomanufacturing + Industry 4.0
2023
Starting construction of the world's largest NGIB production line (Hubei)
Establishment of Weiqi Bio dedicated to industrial scale-up
Achieve tens of millions of yuan in PHA product orders
Bring breakthrough solutions for eco-friendly materials.
  • 1994
    The founder returned to China and joined Tsinghua University.
    Commencing 30 years of research in synthetic biology.
  • 2021
    PhaBuilder Company Established
    Takes the lead in completing 200-ton scale production
  • 2022
    Establishment of a Flexible Manufacturing Line (Beijing)
    Create a Benchmark for Biomanufacturing + Industry 4.0
  • 2023
    Starting construction of the world's largest NGIB production line (Hubei)
    Establishment of Weiqi Bio dedicated to industrial scale-up
    Achieve tens of millions of yuan in PHA product orders
    Bring breakthrough solutions for eco-friendly materials.
Management Team
Composed of individuals from academia, business, and industry.
Professor Guoqiang Chen
Director of the Center for Synthetic and Systems Biology at Tsinghua University
Professor Guoqiang Chen is a leading global expert in synthetic biology and a pioneering figure in the field of metabolic engineering. He serves as a professor at Tsinghua University and is the director of the Center for Synthetic and Systems Biology. He is the principal scientist for the National 973 "Synthetic Biology" project and a major national special project. He is also the first Chinese recipient of the "International Metabolic Engineering Award (IMES Award)."
Professor Chen is also the co-editor-in-chief of the world-renowned journal in synthetic biology, Synthetic and Systems Biotechnology (known as SSB). He has published over 400 papers on microbial technology and biomaterials in international academic journals such as Chemical Reviews and Chemical Society Reviews. His work has been cited over 25,000 times according to Web of Science, with an H-index of 78. He has been granted more than 50 patents and has 50 patents pending.
Xuanming Xu
Chairman of PhaBuilder
Ms. Xu Xuanming, as the Chairman of PhaBuilder, has always been committed to introducing innovative management mechanisms and accelerating the global business layout, aiming to make PhaBuilder a leading enterprise serving the world with synthetic biology.
Ms. Xu Xuanming has been dedicated to the cause of low-carbon sustainable development for a long time. With nearly 20 years of senior management experience in multinational companies, she has served in the Fortune Global 500 company Siemens, empowering the company's digital transformation with an international perspective, achieving ESG goals, and promoting the construction and implementation of standard systems and landmark projects in China's low-carbon related industries. She has led the exploration of innovative solution businesses from scratch and has profound accumulation in the strategic positioning, product development, marketing, industrial chain integration, and innovative models of multinational enterprises.
She firmly believes that PhaBuilder can benefit humanity with the concept of "using microbes to change the world, building a green future." With the "next-generation industrial biotechnology" as the engine, it will create high-performance materials for various industries, apply them to ever-changing scenarios, make PHA Life a new lifestyle concept that is deeply rooted in people's hearts, and continue to promote humanity towards a green future. Ms. Xu Xuanming graduated from the Department of Thermal Engineering at Tsinghua University with a bachelor's degree, and obtained a master's degree in International Business Administration from the School of Economics and Management of Tsinghua University and MIT Sloan School of Management. She later explored entrepreneurship and innovation at the Anderson School of Management at UCLA and Stanford Graduate School of Business in the United States.
  • Fuqing Wu
    Co-founder
    Mr. Wu Fuqing is an expert in synthetic biology and the transformation of scientific research achievements. He is a Ph.D., a member of the Beijing Municipal Committee, a member of the Bio-based Materials Committee of the Chinese Society of Biotechnology, and an associate researcher at the School of Life Sciences, Tsinghua University. Mr. Wu has extensive experience in the field of synthetic biology research and the transformation of industrial achievements. He has presided over three National Natural Science Foundation projects, published more than 40 papers, and applied for 15 patents.
  • Yuxuan Lan
    VP
    A globally renowned entrepreneur leader in the field of synthetic biology, he has a profound understanding of global synthetic biology market trends and industrial development.
    In 2021, as a founding team member, he co-founded the innovative synthetic biology company PhaBuilder, promoting the marketization of synthetic biology products including PHA and tetrahydropyridine using a new halophilic bacterial chassis.
  • Ouyang Pengfei
    VP
    He holds a Ph.D. in Biology from Tsinghua University and he is a postdoctor in Business Administration. With nearly 10 years of frontline research experience in the field of synthetic biology and bioengineering, he has published and applied for multiple SCI papers and invention patents. During his academic years, he served as the chairman of the Graduate Student Union of the School of Life Sciences at Tsinghua University. After 2018, he engaged in industrial consulting research and entered the co-cultivation postdoctoral research at the School of Economics and Management of Tsinghua University, serving as a research assistant. He has an in-depth understanding of the analysis and investment of new global life and health technologies and industries. In 2020, he worked at the Venture lab of DeepTech, engaging in the incubation and investment of synthetic biology. In 2023, he joined PhaBuilder in Beijing as the Vice President.
  • Jinghui Wang
    VP of R&D
    With nearly 11 years of work experience in technology research and development, he served as a senior manager at L'Oréal, possessing extensive management experience in the upstream, midstream, and downstream of R&D. He coordinated and advanced global innovation projects and established a synthetic biology platform. He holds a Ph.D. in Chemical and Bioengineering.
  • Lishuang Cong
    Deputy General Manager of Production
    With 12 years of experience in the research and development, production, industrial scale-up, and the entire GMP production process of fermentation-based APIs (Active Pharmaceutical Ingredients) and pharmaceutical intermediates; proficient in factory management with experience in managing tens of thousands of tons of production. Holds a master's degree in microbiology and is a senior engineer.
Corporate Honors
The Entrepreneurial Journey, Coming with Honors
Zhongguancun High-tech Enterprise
The 8th
High-tech Enterprise
Beijing’s “Specialized, Specialized and New” Small and Medium-sized Enterprises